Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis
Related Experiment Video
Updated: Oct 9, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
F Villani1, R Spreafico, L Farina
1Division of Clinical Neurophysiology and Epileptology, Istituto Nazionale Neurologico "C. Besta," Milan, Italy. neurofisiologia@istituto-besta.it
Abstract:
Rasmussen's encephalitis (RE) is a rare and progressive neurologic condition of uncertain etiology that typically has a childhood onset. The authors describe a 45-year-old woman with adult-onset progressive aphasia, right hemiparesis, severe drug refractory epilepsy, and left cerebral hemisphere atrophy. High-dose corticosteroids and plasmapheresis were not effective. She improved with high-dose therapy with human IV immunoglobulin.
More Related Videos
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
08:38Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Published on: April 9, 2012
Related Concept Videos
Encephalitis l: Introduction
Rocky Mountain Spotted Fever
Encephalitis ll: Pathophysiology